Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. (vol 24, pg 670, 2005)

被引:0
|
作者
Shinefield
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:983 / 983
页数:1
相关论文
共 50 条
  • [21] Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin (vol 31, pg 1166, 2012)
    Rueger, G.
    Gabutti, G.
    Ruemke, H.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (12) : 1319 - 1319
  • [22] Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India (vol 14, pg 1370, 2007)
    Raut, S. K.
    Kulkarni, P. S.
    Phadke, M. A.
    Jadhav, S. S.
    Kapre, S. V.
    Dhere, R. M.
    Dhorje, S. P.
    Godse, S. R.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (07) : 1144 - 1144
  • [23] Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12-to 23-month-old children
    Yetman, Robert J.
    Shepard, Julie S.
    Duke, Anton
    Stek, Jon E.
    Petrecz, Maria
    Klopfer, Stephanie O.
    Kuter, Barbara J.
    Schoedel, Florian P.
    Lee, Andrew W.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (08) : 1691 - 1697
  • [24] A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra ⟨trade⟩): Immunogenicity and safety profile (vol 27, pg 6504, 2009)
    Czajka, Hanna
    Schuster, Volker
    Zepp, Fred
    Esposito, Susanna
    Douha, Martine
    Willems, Paul
    VACCINE, 2010, 28 (52) : 8352 - 8352
  • [25] Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study
    MacDonald, Shannon E.
    Dover, Douglas C.
    Simmonds, Kimberley A.
    Svenson, Lawrence W.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (11) : 824 - 829
  • [26] Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial (vol 383, pg 1313, 2014)
    Prymula, R.
    Bergsaker, Riise M.
    Esposito, S.
    LANCET, 2020, 395 (10220): : 272 - 272
  • [27] Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB(R) vaccines in healthy children twelve to eighteen months old
    Reuman, PD
    Sawyer, MH
    Kuter, BJ
    Matthews, H
    Cashmore, T
    Dubey, L
    Luevanos, L
    IbarraPratt, EY
    Nelle, CA
    White, CJ
    Stinson, D
    Cho, I
    Clements, D
    Walter, EB
    Keyserling, H
    Padrick, C
    Blatter, MM
    Reisinger, KS
    Laufer, D
    Watson, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (07) : 662 - 667
  • [28] Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and varicella zoster virus (vol 126, pg 1289, 2001)
    Buxbaum, S
    Doerr, HW
    Allwinn, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (23) : 1278 - 1278
  • [29] Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore A phase II, randomized, double-blind trial
    Huang, Li-Min
    Lee, Bee-Wah
    Chan, Poh Chong
    Povey, Michael
    Henry, Ouzama
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (06) : 1308 - 1315
  • [30] Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study
    Liu, Yuanbao
    Liu, Zhihao
    Deng, Xiuying
    Hu, Ying
    Wang, Zhiguo
    Lu, Peishan
    Guo, Hongxiong
    Sun, Xiang
    Xu, Yan
    Tang, Fenyang
    Zhu, Feng-Cai
    EXPERT REVIEW OF VACCINES, 2018, 17 (05) : 445 - 452